BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23986199)

  • 1. Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.
    Walker AL; Lancaster CS; Finkelstein D; Ware RE; Sparreboom A
    Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1223-9. PubMed ID: 23986199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell anemia: time for personalized prescription of hydroxyurea? Focus on "Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics".
    Thornburg CD
    Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1209-10. PubMed ID: 24005044
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters.
    Walker AL; Franke RM; Sparreboom A; Ware RE
    Exp Hematol; 2011 Apr; 39(4):446-56. PubMed ID: 21256917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OATP1A/1B transporters affect irinotecan and SN-38 pharmacokinetics and carboxylesterase expression in knockout and humanized transgenic mice.
    Iusuf D; Ludwig M; Elbatsh A; van Esch A; van de Steeg E; Wagenaar E; van der Valk M; Lin F; van Tellingen O; Schinkel AH
    Mol Cancer Ther; 2014 Feb; 13(2):492-503. PubMed ID: 24194565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
    Prueksaritanont T; Chu X; Evers R; Klopfer SO; Caro L; Kothare PA; Dempsey C; Rasmussen S; Houle R; Chan G; Cai X; Valesky R; Fraser IP; Stoch SA
    Br J Clin Pharmacol; 2014 Sep; 78(3):587-98. PubMed ID: 24617605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.
    Lee HH; Leake BF; Kim RB; Ho RH
    Mol Pharmacol; 2017 Jan; 91(1):14-24. PubMed ID: 27777271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin.
    Zaher H; Meyer zu Schwabedissen HE; Tirona RG; Cox ML; Obert LA; Agrawal N; Palandra J; Stock JL; Kim RB; Ware JA
    Mol Pharmacol; 2008 Aug; 74(2):320-9. PubMed ID: 18413659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of Organic Anion Transporting Polypeptide (OATP) 1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Downregulation in Cynomolgus Monkeys Treated with Chenodeoxycholic Acid.
    Zhang Y; Chen SJ; Chen C; Chen XQ; Chatterjee S; Shuster DJ; Dexter H; Armstrong L; Joshi EM; Yang Z; Shen H
    Drug Metab Dispos; 2022 Aug; 50(8):1077-1086. PubMed ID: 35636769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
    Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
    Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
    Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
    Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Determinants of Daprodustat Drug-Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B-CYP2C8 Interplay.
    Bi YA; Jordan S; King-Ahmad A; West MA; Varma MVS
    Clin Pharmacol Ther; 2024 Jun; 115(6):1336-1345. PubMed ID: 38404228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression.
    Zhang Y; Chen C; Chen SJ; Chen XQ; Shuster DJ; Puszczalo PD; Fancher RM; Yang Z; Sinz M; Shen H
    J Pharmacol Exp Ther; 2020 Oct; 375(1):139-151. PubMed ID: 32719071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics.
    Robbins JA; Menzel K; Lassman M; Zhao T; Fancourt C; Chu X; Mostoller K; Witter R; Marceau West R; Stoch SA; McCrea JB; Iwamoto M
    Clin Pharmacol Ther; 2022 Mar; 111(3):664-675. PubMed ID: 34888851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice.
    Bechtold BJ; Lynch KD; Oyanna VO; Call MR; White LA; Graf TN; Oberlies NH; Clarke JD
    Drug Metab Dispos; 2024 Apr; 52(5):355-367. PubMed ID: 38485280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition.
    Gu X; Wang L; Gan J; Fancher RM; Tian Y; Hong Y; Lai Y; Sinz M; Shen H
    Drug Metab Dispos; 2020 Aug; 48(8):724-734. PubMed ID: 32482623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.
    Wiczling P; Liem RI; Panepinto JA; Garg U; Abdel-Rahman SM; Kearns GL; Neville KA
    J Clin Pharmacol; 2014 Sep; 54(9):1016-22. PubMed ID: 24729271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model.
    Bechtold BJ; Lynch KD; Oyanna VO; Call MR; Graf TN; Oberlies NH; Clarke JD
    Mol Pharm; 2024 May; 21(5):2284-2297. PubMed ID: 38529622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.
    Estepp JH; Wiczling P; Moen J; Kang G; Mack JM; Liem R; Panepinto JA; Garg U; Kearns G; Neville KA
    Br J Clin Pharmacol; 2018 Jul; 84(7):1478-1485. PubMed ID: 28884840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.
    Lancaster CS; Sprowl JA; Walker AL; Hu S; Gibson AA; Sparreboom A
    Mol Cancer Ther; 2013 Aug; 12(8):1537-44. PubMed ID: 23757163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.
    Csanaky IL; Lu H; Zhang Y; Ogura K; Choudhuri S; Klaassen CD
    Hepatology; 2011 Jan; 53(1):272-81. PubMed ID: 20949553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.